Clinical News

The policy led to $23 million in cost savings within the first 12 months.

The EUA submission includes data from the company’s interim analysis of the Phase 2/3 EPIC-HR clinical trial.

An investigation examines whether safety communications from the US Food and Drug Administration (FDA) in 2017 and 2018 led to reductions in the prescription of cough and cold medications with codeine and hydrocodone.

The CDC encourages health care professionals to get involved in antibiotic resistance awareness.

Results of a phase 4 study showed erenumab to be superior in efficacy and tolerability outcomes among migraineurs compared with topiramate.

One year after the close of the Increasing Access to Contraception (IAC) Learning Community, participants had sustained their efforts in support of at least 1 goal: to improve adolescent girls' and women’s access to the full range of contraceptive options.

Although the authors say their findings shed light on possible disruptions to insulin supply during COVID-19, they note they could not adjust for those with diabetes who died.

The company plans to submit these results to the FDA and EMA for review.

Non-White patients were more likely to express beliefs that medications are both harmful and overused, leading to a decrease in medication adherence.

The FDA has approved Dyanavel XR, extended release once-daily tablets for the treatment of attention-deficit/hyperactivity disorder.

Patients with rheumatoid arthritis should be encouraged to receive their yearly flu vaccine.

Patients require more information on biosimilars, but the number of switches a patient experience does not negatively impact their satisfaction with care.

Pharmacists are a key part of the multidisciplinary approach that health care providers should take when tapering patients off opioid therapy.

Fewer patients today are likely to express an unwillingness to change their RA medications compared with patients 15 years ago, survey results showed.

A poster presentation at ACR Convergence 2021 compared risk factors for long-term opioid use among DMARD and non-DMARD users.

The vaccine’s safety, tolerability, and efficacy was discussed across multiple abstracts presented at ACR Convergence 2021.

Patients with fibromyalgia are turning to medical cannabis to improve sleep problems and other negative effects, according to a poster presentation at ACR Convergence 2021, the American College of Rheumatology’s annual meeting.

The study, presented at ACR Convergence 2021, evaluated how methotrexate self-injection education videos on YouTube have evolved over time.

Patients with post-acute COVID syndrome, or “long COVID,” can experience symptoms for at least 12 months, investigators reported.

Here’s a roundup of the latest news from Drug Topics®.

The next step in the approval process is the formal acceptance of the recommendation by CDC Director Rochelle P. Walensky, MD, MPH.

FDA gives OK to shingles vaccine for those at risk

Here’s a roundup of the latest news coverage from Drug Topics®.

Here’s a roundup of the latest news coverage from Drug Topics®.

Dapagliflozin (Farxiga; AstraZeneca) is the first SGLT2 inhibitor approved for the treatment of chronic kidney disease regardless of diabetes status.

Starting February 11, federal vaccine supplies will be delivered directly to select pharmacies, according to the announcement.

Here’s a roundup of the latest coronavirus-related news:

A look back at the most impressive drug approvals and product launches of the year.

How will independent community pharmacies fare with Amazon’s encroachment into the pharmacy space?